Programme

Keywords
PDF version

Wed 23 Oct

10:00

e-poster session day 1

to
Digital kiosks
e-poster session

11:50

Sex, gender and diversity in drugs

to
Auditorium IV
Oral presentation session

Advancing addiction research: global perspectives and collaborative initiatives

to
Auditorium VI
Oral presentation session

Lives at risk: mental health and substance use

to
Auditorium VII
Oral presentation session

Prevalence of opioids and related harms

to
Auditorium VIII
Oral presentation session

Mechanisms and outcomes in substance use prevention among youth

to
Room 5A
Oral presentation session

Building addiction workforce capacity

to
Room 5C
Oral presentation session

Evaluation of drug consumption rooms: guidance step by step

to
Room 1.15
Workshop

14:20

Enhancing access to harm reduction services in community and prisons: experiences of translating policy into practice and scaling interventions

to
Auditorium I
Major session

Drug policy and the criminal legal system

to
Auditorium VI
Oral presentation session

Challenge of measuring use and impact of cannabinoids

to
Room 1.07
Oral presentation session

Methods and measurement

to
Room 1.08
Short communication session

The peer model: the critical role of ethics in efficacy

to
Room 1.15
Workshop

16:00

Challenges in community-based prevention

to
Auditorium I
Major session

The recovery journey

to
Auditorium III
Oral presentation session

Infectious diseases in people who inject drugs

to
Auditorium IV
Oral presentation session

Measuring drug market phenomenon

to
Auditorium VI
Oral presentation session

Surveillance of drug-related morbidity and mortality

to
Room 5A
Oral presentation session

Inequalities and needs of migrant groups

to
Room 5C
Oral presentation session

Quality in addictions work systems

to
Room 1.06
Oral presentation session

Problematic gambling and gaming

to
Room 1.07
Short communication session

Conceptualising health and harms

to
Room 1.08
Short communication session

17:50

Drug use trends

to
Auditorium IV
Oral presentation session

Psychedelics 1

to
Auditorium VIII
Oral presentation session

Novel and contextual approaches in prevention

to
Room 5A
Oral presentation session

Opioid treatment 1

to
Room 5B
Oral presentation session

Motivations for use

to
Room 5C
Oral presentation session

Hepatitis C, HIV, and other drug related harms

to
Room 1.05
Short communication session

Opioids: trends, use and treatments

to
Room 1.06
Short communication session

19:30

Why are we not doing better at reducing drug-related deaths?

to
Auditorium I
Big debate

Thu 24 Oct

11:50

Opioid Agonist Treatment: novel formulations and challenges

to
Auditorium IV
Oral presentation session

Evidence informed drug and alcohol policy

to
Auditorium VI
Oral presentation session

Emerging drug harms, DCRs and other responses

to
Auditorium VII
Short communication session

Innovative methods for understanding drug markets and policy

to
Room 5A
Oral presentation session

Workers reaching marginalised groups

to
Room 5C
Oral presentation session

Contemporary issues

to
Room 1.08
Oral presentation session

Back-casting exercise on peer-support workforce development

to
Room 1.15
Workshop

14:20

Understanding drug-related deaths

to
Auditorium IV
Oral presentation session

Conceptual frameworks for studying drug policy

to
Auditorium VI
Oral presentation session

Young people, mental health and substance use

to
Auditorium VII
Oral presentation session

Co-creating robust systems with workers

to
Room 5C
Oral presentation session

Understanding harm reduction: economic, social, and health perspectives

to
Room 1.05
Short communication session

Women's realities of drug use

to
Room 1.08
Oral presentation session

16:00

Hepatitis C testing and treatment

to
Auditorium IV
Oral presentation session

From genes to brains

to
Room 1.06
Short communication session

City insights: creating a collaborative network for city-level monitoring of drug trends and harm reduction

to
Room 1.07
Workshop

17:50

Mixed methods for understanding drug use

to
Auditorium III
Oral presentation session

Substance use and mental health in treatment settings

to
Auditorium VII
Oral presentation session

Misuse of medicines

to
Auditorium VIII
Oral presentation session

From old to new: changes in drug use

to
Room 5C
Oral presentation session

Fri 25 Oct

11:50

Intentional and non-intentional drug-related deaths

to
Auditorium IV
Oral presentation session

Psychedelics 2

to
Auditorium VI
Oral presentation session

Drugs checking services

to
Room 5A
Oral presentation session

Online monitoring

to
Room 5B
Oral presentation session

Emerging challenges in drug markets: monitoring, measurement & impacts

to
Room 1.05
Short communication session

Gaming and health

to
Room 1.06
Short communication session

Support for the addiction workforce

to
Room 1.07
Oral presentation session

14:20

Young people and drugs

to
Auditorium III
Oral presentation session

Overdose prevention

to
Auditorium IV
Oral presentation session

Holistic care for mental well-being

to
Room 1.05
Short communication session